SWFs Search for New Avenues to Access US Biotech

April 12, 2017 by Loch Adamson

  • Print
  • Please login
Last week, an unlikely duo of giant sovereign wealth funds from Abu Dhabi and Singapore seek to acquire stakes in a US clinical trials company, Norway's government considers relaxing investment rules for the Government Pension Fund Global, and Abu Dhabi's Mubadala moves on step closer to its merger with the International Petroleum Investment Co. ADIA and GIC Negotiate for Stakes in US Clinical Trials Company Sovereign wealth funds continue to explore new ways to invest capital in cutting-edge technology – and this week, news emerged that Singapore’s GIC and the Abu Dhabi Investment Authority (ADIA) are in advanced talks with US buyout firms, the Carlyle Group and Hellman & Friedman, about buying minority stakes in Pharmaceutical Product Development (PPD), a global clinical trials company based in Wilmington, North Carolina. The proposed terms of the deal would assign a valuation in excess of $9 billion to PPD, which provides…

Sign-up for your free account to read this article

Get Started

Already have an account?
 

Log In Here

Updated Fund Profiles

Our market-leading fund profile library provides unrivalled analysis of more than 90 government and sovereign funds.

Register to read fund profiles

Recent SWF Investments

Search the database of direct investments and mandates by fund, industry and target market to identify past deals that match your requirements. Access over $1 trillion worth of transactions dating back to the 1960s.

Register to explore our data

Latest SWF News

Sovereign Wealth Center makes staying abreast of the most recent government and sovereign fund events easy. Our team undertakes a thorough review of global news feeds every morning and distills salient points.

Register for the latest SWF news
Join the discussion:

To be able to print this content,
you must be a subscriber

For details on your subscription options,
please contact: